a PCR test ready before the outbreak

  1. Donation campaign June 2022

    Dear reader friends. We are launching a new donation campaign for this month of June and we are counting on you to help us continue our information work. As you know, there is a cost to maintaining and running our site, and we depend almost entirely on your donations to fund it. Réseau International needs you more than ever to ensure the continuity of its work of reflection and re-information

    Total donations €4,295.00

While France is on alert because the country had 16 cases of people infected with monkeypox on May 29, 2022 and the High Authority for Health already recommended on May 24 to vaccinate health professionals and contact cases, we find that a monkeypox study by scientists from the P4 laboratory in Wuhan and the Chinese Academy of Sciences University was published in February 2022. It demonstrates that a PCR testing technique for detect the virus has been developed.

L’studytransmitted in August 2021, was validated and published in February 2022 a few months before the official appearance of the first case monkeypox in May 2022.

A study aimed at to be able todetect the virus

To sum up the study, the researchers succeeded in developing a DNA sequencing technique that allows PCR tests to recognize the virus. They refer to an “efficient assembly of a large fragment of the monkeypox virus genome as a qPCR model using recombination associated with transformation based on double selection”.

This is a new technique for detecting a virus by quantitative PCR which is presented here: it consists of integrating segments of the monkeypox genome with genetic sequences of yeasts which make it possible to read, label by fluorescence and amplify the genetic segments of the virus sought. In this case, the Chinese researchers acquired synthetic sequences of the monkeypox virus genome which correspond to “less than one third of the total genome”, specifies the study. This for obvious security reasons: assembling the whole virus would certainly make it possible to detect it in its entirety, would make it more visible at the time of PCR amplification and would reduce the risk of obtaining false positives. But reconstituting it whole could however make it infectious.

This is the risk that a group of Chinese-American researchers took in 2017 during research on vaccination against the horsepox virus. Scientists from the American biotechnology company “Tonix pharmaceuticals” had indeed proposed to completely assemble this virus on the basis of synthetic DNA sequences. The assembly obtained therefore conferred on this new virus all of its infectivity and toxicity properties. A risk that Wuhan researchers say they wanted to rule out.

Existing risks

These manipulations are nevertheless not without danger since, whatever they are, the viruses studied in the laboratory and in certain cases transformed following gains in function can escape from them. In the case of the study concerned in this article, the scientists recognize that not all the consequences of such recombinations are under control which could “raise potential safety problems, in particular when the assembled product contains a complete set of genetic material recoverable in a contagious pathogen”.

But as with the causal link between vaccines and side effects, it seems difficult to prove the one likely to exist between a virus escaped from a laboratory and a pandemic, which may have been the case for Covid- 19, a hypothesis long refuted by the media, then rehabilitated.

It should be remembered that research on coronaviruses was carried out at the Wuhan laboratory and it is strongly believed that genetic manipulations may have been carried out there.

Today, there may even be talk that Mr. Stéphane Bancel, CEO of Moderna, could be one of those responsible for the spread of Covid-19. Interviewed by a Fox Business journalist in February 2022 who asked him if a sequence found in the RNA of SARS-CoV-2 was indeed identical to that patented by the American pharmaceutical laboratory in 2017, Mr. Bancel admitted that a leak laboratory was not excluded, that the error was human and that a team of scientists was verifying these data. We are still awaiting the results…

Running gag or more wisdom coming ?

In the case of monkeypox, will the assumption of a link between a laboratory virus and a real epidemic again be mocked and accused of conspiracy, then accepted without any apology towards the first whistleblowers? Will we this time find proof of a concrete link between an animal and the form of the virus which is currently spreading among human beings, as is still not the case with Covid-19? If we find patent holders possibly responsible for the spread of a virus like Stéphane Bancel, will they kick as he did and continue to sell their vaccine “remedies”, in the greatest media silence and with impunity? If today, we cannot say anything, it seems important to us to remain vigilant.

source: Nexus

Leave a Comment